CompuGroup Medical SE & Co. KGaA (ETR:COP), might not be a large cap stock, but it saw significant share price movement during recent months on the XTRA, rising to highs of €39.54 and falling to the lows of €33.00. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether CompuGroup Medical SE KGaA's current trading price of €36.30 reflective of the actual value of the mid-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let’s take a look at CompuGroup Medical SE KGaA’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change.

View our latest analysis for CompuGroup Medical SE KGaA

Is CompuGroup Medical SE KGaA Still Cheap?

Great news for investors – CompuGroup Medical SE KGaA is still trading at a fairly cheap price. According to our valuation, the intrinsic value for the stock is €55.95, but it is currently trading at €36.30 on the share market, meaning that there is still an opportunity to buy now. What’s more interesting is that, CompuGroup Medical SE KGaA’s share price is quite volatile, which gives us more chances to buy since the share price could sink lower (or rise higher) in the future. This is based on its high beta, which is a good indicator for how much the stock moves relative to the rest of the market.

Can we expect growth from CompuGroup Medical SE KGaA?

Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. CompuGroup Medical SE KGaA's earnings over the next few years are expected to increase by 62%, indicating a highly optimistic future ahead. This should lead to more robust cash flows, feeding into a higher share value.

What This Means For You

Are you a shareholder? Since COP is currently undervalued, it may be a great time to accumulate more of your holdings in the stock. With a positive outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as capital structure to consider, which could explain the current undervaluation.

Are you a potential investor? If you’ve been keeping an eye on COP for a while, now might be the time to make a leap. Its buoyant future outlook isn’t fully reflected in the current share price yet, which means it’s not too late to buy COP. But before you make any investment decisions, consider other factors such as the strength of its balance sheet, in order to make a well-informed investment decision.

If you want to dive deeper into CompuGroup Medical SE KGaA, you'd also look into what risks it is currently facing. In terms of investment risks, we've identified 1 warning sign with CompuGroup Medical SE KGaA, and understanding this should be part of your investment process.

If you are no longer interested in CompuGroup Medical SE KGaA, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.